Table 1.

Nivolumab treatment in mRCC patients that underwent dialysis

	Age, years	Gender	Pathology	TNM stage	Prior treatment	Time from diagnosis to nivolumab
Carloet al.	77	Male	Clear cell	pT2aNxM0	Partial nephrectomy, radical nephrectomy, pazopanib, everolimus, sorafenib	2 years, 10 months
Tabei et al.	49	Male	Clear cell	pT1bNxM1	Radical nephrectomy, Interferon alpha, sorafenib, everolimus, sunitinib, axitinib, pazopanib	8 years, 11 months
Current case	68	Male	Clear cell + papillary	pT1aN1M0	Radical nephrectomy, sunitinib	2 years, 4 months